Disgust, Horror, and “Elimination”: Trump and RFK Jr.’s Eugenicist Autism Conference
By Julie Métraux,
Mother Jones
| 09. 23. 2025
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
On Monday, President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. held a press conference on their attempts to divine the causes of autism—much to the chagrin of many autistic adults, who were completely excluded from the process. The two, alongside administration officials including Centers for Medicare and Medicaid Services Administrator Mehmet Oz, claimed without definitive scientific evidence that Tylenol during pregnancy, one of the only means to treat fever, was a leading factor in children becoming autistic—demanding, in Trump’s case, that women discontinue its use.
Trump announced within the first ten minutes of the conference that the National Institutes of Health, “to help reach the ultimate goal of ending the autism,” would launch some 13 research grants to address what Kennedy called the “autism epidemic” and “how patients and parents can prevent and reverse this alarming trend.”
Trump’s long history of being obsessed with eugenics, and of ableist statements, set the tone for a press conference that rejected the idea of autistic...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
